NEWS

Our Latest News

Majority owner ARCHIMED and its partners fund three add-on acquisitions by diversified European health safety testing company, CARSO
Majority owner ARCHIMED and its partners fund three add-on acquisitions by diversified European health safety testing company, CARSO

ARCHIMED buys WiQo, a pioneer in the field of aesthetic medicine

 March

 9, 

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

 October

 7, 

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

 October

 4, 

2022

ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal

 July

 21, 

2022

ARCHIMED invests in Title21 Health Solutions, a leading US-based healthcare software provider

 July

 12, 

2022

ARCHIMED invests in Corealis Pharma, a North American CDMO, through MED III

 May

 24, 

2022

1 2 3 4 5 … 14
368